CN1970021A - Chinese medicine for treating gout and preparation method thereof - Google Patents
Chinese medicine for treating gout and preparation method thereof Download PDFInfo
- Publication number
- CN1970021A CN1970021A CN 200610135265 CN200610135265A CN1970021A CN 1970021 A CN1970021 A CN 1970021A CN 200610135265 CN200610135265 CN 200610135265 CN 200610135265 A CN200610135265 A CN 200610135265A CN 1970021 A CN1970021 A CN 1970021A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- preparation
- goat
- treatment
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Chinese medicament for treating gout and process for preparation, wherein the medicament is prepared from poria cocos, polyporus umbellatus, oriental water plantain rhizome, white atractylodes rhizome and cassia twig through steps of mixing raw materials, extracting with water, concentrating into grease form extract, charging auxiliary materials containing lactose and starch gum.
Description
Technical field
The present invention relates to the raw material and the preparation method of medicine, more specifically relate to a kind of Chinese medicine for the treatment of goat and preparation method thereof.
Background technology
Goat is a kind of disease of Metabolic disorder, and its cause of disease is that uric acid metabolism causes blood uric acid too high unusually.Its clinical characters is that blood uric acid increases, and uric acid crystal is deposited on cartilage, osteoarthrosis and brings out acute arthritis, and often outbreak repeatedly also can form gouty arthritis,chronic and joint deformity.For the clinical treatment of gout, the main chemotherapeutics that adopts on the modern doctor trained in Western medicine, as colchicine, allopurinol etc., the person of being in a bad way adds and uses hormone, and its side effects of pharmaceutical drugs are very big, but curative effect is very little.Modern Chinese medicine is relatively more chaotic to the understanding of gout, so the method for many Chinese traditional treatment gouts is to dispel the wind, pain relieving, invigorate blood circulation, rather than falls blood uric acid; Yet do not have the Chinese patent medicine that can reduce blood uric acid truly on the market at present,, do not have curative effect clinically though the Tibetan medicine that has propaganda can reduce blood uric acid.
Summary of the invention
The present invention seeks at the problems referred to above, a kind of Chinese medicine for the treatment of goat and preparation method thereof is provided.
The present invention is a kind of to be treated in the composition of raw materials of Chinese medicine of goat and comprises at least: Poria, Polyporus, Rhizoma Alismatis, the Rhizoma Atractylodis Macrocephalae and Ramulus Cinnamomi; This preparation method of Chinese medicine is: each raw material is mixed in proportion, with water extraction 2 times, is condensed into and adds the adjuvant that contains lactose, dextrin after the paste extract and make patent medicine, the weight ratio of adjuvant and paste extract is 40～60%.
Advantage of the present invention is: according to the understanding of goat and patient's clinical manifestation, the present invention has selected five kinds of Chinese medicines (Rhizoma Atractylodis Macrocephalae, Poria spleen invigorating for use, Rhizoma Alismatis, Polyporus diuretic, Ramulus Cinnamomi warming YANG activating QI) as the raw material of drug regimen of treatment goat, full side has invigorating spleen to remove dampness, the effect of warming YANG activating QI.Clinical effective rate almost reaches 100%, and the 7 days blood uric acids of taking medicine can be reduced to normally, and the normal back of blood uric acid calculi in vivo can be organized absorption, arthritis, renal calculus spontaneous recovery gradually.This medicine is the method for fundamentally treating goat, demonstrated fully the spirit that the traditional Chinese medical science " is cured the disease and must be asked it ", and the preparation method of this medicine is simple, with low cost.
The specific embodiment
Is Poria 15～30% with medicine material according to weight ratio, Polyporus 15～30%, Rhizoma Alismatis 15～30%, the Rhizoma Atractylodis Macrocephalae 15～30%, Ramulus Cinnamomi 15～30% takes by weighing, clean to pulverize the back with water extraction 2 times, be condensed into and add the adjuvant that contains lactose, dextrin after the paste extract and make patent medicine, the weight ratio of adjuvant and paste extract is 40～60%.
Wherein, patent medicine is capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill.
Claims (4)
1. a Chinese medicine for the treatment of goat is characterized in that: comprise at least in the composition of raw materials of described Chinese medicine: Poria, Polyporus, Rhizoma Alismatis, the Rhizoma Atractylodis Macrocephalae and Ramulus Cinnamomi.
2. a kind of Chinese medicine for the treatment of goat according to claim 1, it is characterized in that: the weight proportion of described each component of Chinese medicine is: Poria 15～30%, Polyporus 15～30%, Rhizoma Alismatis 15～30%, the Rhizoma Atractylodis Macrocephalae 15～30%, Ramulus Cinnamomi 15～30%.
3. a kind of preparation method of Chinese medicine for the treatment of goat as claimed in claim 1 or 2, it is characterized in that: each raw material is mixed in proportion, with water extraction 2 times, be condensed into and add the adjuvant that contains lactose, dextrin after the paste extract and make patent medicine, the weight ratio of adjuvant and paste extract is 40～60%.
4. a kind of preparation method of Chinese medicine for the treatment of goat according to claim 3 is characterized in that: described patent medicine is capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610135265 CN1970021A (en) | 2006-11-29 | 2006-11-29 | Chinese medicine for treating gout and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610135265 CN1970021A (en) | 2006-11-29 | 2006-11-29 | Chinese medicine for treating gout and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1970021A true CN1970021A (en) | 2007-05-30 |
Family
ID=38111169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610135265 Pending CN1970021A (en) | 2006-11-29 | 2006-11-29 | Chinese medicine for treating gout and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1970021A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101856439A (en) * | 2010-04-28 | 2010-10-13 | 浙江泰康药业集团新余制药有限公司 | Chestnutsdispe capsule and preparation method thereof |
| CN102652761A (en) * | 2011-03-02 | 2012-09-05 | 昆明制药集团股份有限公司 | Composition with blood uric acid adjusting function |
| CN103316167A (en) * | 2013-01-03 | 2013-09-25 | 秦世昌 | Traditional Chinese medicine formula for treatment of ''condyloma'' |
| CN106236978A (en) * | 2016-08-30 | 2016-12-21 | 吉林紫鑫药业股份有限公司 | A kind of pharmaceutical composition for treating acute gastroenteritis |
| CN106266341A (en) * | 2016-08-30 | 2017-01-04 | 长沙佰顺生物科技有限公司 | A kind of Chinese medicine composition treating gout |
| CN111920924A (en) * | 2020-08-04 | 2020-11-13 | 深圳市宝安中医院（集团） | Traditional Chinese medicine composition for reducing uric acid and preparation method thereof |
-
2006
- 2006-11-29 CN CN 200610135265 patent/CN1970021A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101856439A (en) * | 2010-04-28 | 2010-10-13 | 浙江泰康药业集团新余制药有限公司 | Chestnutsdispe capsule and preparation method thereof |
| CN101856439B (en) * | 2010-04-28 | 2012-07-04 | 浙江泰康药业集团新余制药有限公司 | Chestnutsdispe capsule and preparation method thereof |
| CN102652761A (en) * | 2011-03-02 | 2012-09-05 | 昆明制药集团股份有限公司 | Composition with blood uric acid adjusting function |
| CN103316167A (en) * | 2013-01-03 | 2013-09-25 | 秦世昌 | Traditional Chinese medicine formula for treatment of ''condyloma'' |
| CN106236978A (en) * | 2016-08-30 | 2016-12-21 | 吉林紫鑫药业股份有限公司 | A kind of pharmaceutical composition for treating acute gastroenteritis |
| CN106266341A (en) * | 2016-08-30 | 2017-01-04 | 长沙佰顺生物科技有限公司 | A kind of Chinese medicine composition treating gout |
| CN111920924A (en) * | 2020-08-04 | 2020-11-13 | 深圳市宝安中医院（集团） | Traditional Chinese medicine composition for reducing uric acid and preparation method thereof |
| CN111920924B (en) * | 2020-08-04 | 2022-04-01 | 深圳市宝安中医院（集团） | Traditional Chinese medicine composition for reducing uric acid and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266520B (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN105412587A (en) | Method for preparing medicine composition for treating female postmenopausal osteoporosis | |
| CN101940716A (en) | Medicament for treating diabetic nephropathy | |
| CN101297889B (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
| CN1970021A (en) | Chinese medicine for treating gout and preparation method thereof | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN101011544A (en) | Gout rapid recovery pill(capsule) and preparation technique thereof | |
| CN101856405B (en) | Medicinal composition for treating type II diabetes mellitus and preparation method thereof | |
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101095768A (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN105031420A (en) | Traditional Chinese medicinal preparation for nursing diabetes mellitus and preparation method thereof | |
| CN101757312A (en) | Chinese medicine preparation for treating thrombocytopenia | |
| CN104107348A (en) | Chinese herbal medicine for blood sugar reducing, and administration method thereof | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
| CN105999058B (en) | Bidens bipinnata lipid-lowering tablet | |
| CN104524342A (en) | Traditional Chinese medicine preparation for lowering high blood pressure, high blood sugar, high cholesterol, high uric acid and maintaining vigor and preparation method of plaster of traditional Chinese medicine preparation | |
| CN101450177A (en) | Traditional Chinese medicine composition with blood sugar reducing function and preparation method thereof | |
| CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN102038827A (en) | Chinese medicinal preparation for treating diabetes with hypertension | |
| CN102293923A (en) | Application of Tibetan medicinal composition to preparation of medicament for preventing and treating osteoporosis | |
| CN101194959B (en) | Capsule for treating headache and method for preparing the same | |
| CN104107352A (en) | Chinese herbal medicine for blood pressure reducing, and administration method thereof | |
| CN103041335A (en) | Traditional Chinese medicine composition for treating gastralgia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20070530 |